tradingkey.logo
tradingkey.logo
Pesquisar

IRadimed Corp

IRMD
Adicionar à lista de desejos
99.463USD
+1.423+1.45%
Fechamento 07/02, 13:00ETCotações atrasadas em 15 min
1.27BValor de mercado
53.66P/L TTM

Mais detalhes de IRadimed Corp Empresa

IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gauss.

Informações de IRadimed Corp

Código da empresaIRMD
Nome da EmpresaIRadimed Corp
Data de listagemJul 16, 2014
CEOSusi (Roger)
Número de funcionários160
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 16
Endereço12705 Ingenuity Drive
CidadeORLANDO
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal32826
Telefone14076778022
Sitehttps://www.iradimed.com/
Código da empresaIRMD
Data de listagemJul 16, 2014
CEOSusi (Roger)

Executivos da empresa IRadimed Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--
Jeffrey Chiprin
Jeffrey Chiprin
Chief Commercial Officer
Chief Commercial Officer
--
--
Mr. Joe Kiani
Mr. Joe Kiani
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. James B. (Jim) Hawkins
Mr. James B. (Jim) Hawkins
Director
Director
29.65K
--
Mr. Monty K. Allen, CPA
Mr. Monty K. Allen, CPA
Independent Director
Independent Director
21.00K
--
Mr. John F. (Jack) Glenn
Mr. John F. (Jack) Glenn
Chief Financial Officer, Corporate Secretary
Chief Financial Officer, Corporate Secretary
17.73K
+19.61%
Mr. Roger Susi
Mr. Roger Susi
Chairman of the Board, President, Chief Executive Officer, Founder
Chairman of the Board, President, Chief Executive Officer, Founder
--
--
Mr. Randy Waddell
Mr. Randy Waddell
Vice President - Worldwide Sales and Marketing
Vice President - Worldwide Sales and Marketing
--
--
Ms. Hilda Scharen-Guivel
Ms. Hilda Scharen-Guivel
Independent Director
Independent Director
--
--

Perguntas frequentes

Quem são os cinco principais acionistas de IRadimed Corp?

Os cinco principais acionistas de IRadimed Corp são: Mr. James B. (Jim) Hawkins

Quantas instituições possuem ações da IRadimed Corp (IRMD)?

Em 2026Q1, 407 instituições possuíam ações da IRadimed Corp, com valor de mercado aproximado de 8.32M, representando 65.08% do total de ações. Em comparação com 2025Q4, a participação institucional aumentou em -453182.00.

Qual é a maior fonte de receita da IRadimed Corp?

Em 2026Q1, o segmento de negócios MRI Compatible IV Infusion Pump Systems gerou a maior receita para IRadimed Corp, totalizando 31.64M e representando 37.75% da receita total.